Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells

被引:93
作者
Prabha, Swayam [1 ]
Labhasetwar, Vinod [1 ,2 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
sustained release; biodegradable polymers; cellular gene delivery; gene transfection; cancer;
D O I
10.1021/mp049970+
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gene expression with nonviral vectors is usually transient and lasts for only a few days. Therefore, repeated injection of the expression vector is required to maintain a therapeutic protein concentration in the target tissue. Biodegradable nanoparticles (similar to 200 nm diameter) formulated using a biocompatible polymer, poly(D,L-lactide-co-glycolide) (PLGA), have the potential for sustained gene delivery. Our hypothesis is that nanoparticle-mediated gene delivery would result in sustained gene expression, and hence better efficacy with a therapeutic gene. In this study, we have determined the antiproliferative activity of wild-type (wt) p53 gene-loaded nanoparticles in a breast cancer cell line. Nanoparticles containing plasmid DNA were formulated using a multiple-emulsion-solvent evaporation technique. To understand the mechanism of sustained gene expression with nanoparticles, we monitored the intracellular trafficking of both the nanoparticles and the nanoparticle-entrapped DNA, and also determined p53 mRNA levels over a period of time. Cells transfected with wt-p53 DNA-loaded nanoparticles demonstrated a sustained and significantly greater antiproliferative effect than those with naked wt-p53 DNA or wt-p53 DNA complexed with a commercially available transfecting agent (Lipofectamine).,Cells transfected with wt-p53 DNA-loaded nanoparticles demonstrated sustained p53 mRNA levels compared to cells which were transfected with naked wt-p53 DNA or the wt-p53 DNA-Lipofectamine complex, thus explaining the sustained antiproliferative activity of nanoparticles. Studies with fluorescently labeled DNA using confocal microscopy and quantitative analyses using a microplate reader demonstrated sustained intracellular localization of DNA with nanoparticles, suggesting the slow release of DNA from nanoparticles localized inside the cells. Cells which were transfected with naked DNA demonstrated transient intracellular DNA retention. In conclusion, nanoparticle-mediated wt-p53 gene delivery results in sustained anti proliferative activity, which could be therapeutically beneficial in cancer treatment.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 43 条
[1]   Localized, direct plasmid gene delivery in vivo:: prolonged therapy results in reproducible tissue regeneration [J].
Bonadio, J ;
Smiley, E ;
Patil, P ;
Goldstein, S .
NATURE MEDICINE, 1999, 5 (07) :753-759
[2]   Gene delivery with synthetic (non viral) carriers [J].
Brown, MD ;
Schätzlein, AG ;
Uchegbu, IF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 229 (1-2) :1-21
[3]   BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS [J].
CAILLEAU, R ;
YOUNG, R ;
OLIVE, M ;
REEVES, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :661-674
[4]   HIGH-EFFICIENCY TRANSFORMATION BY DIRECT MICRO-INJECTION OF DNA INTO CULTURED MAMMALIAN-CELLS [J].
CAPECCHI, MR .
CELL, 1980, 22 (02) :479-488
[5]  
Chen Qing-Rong, 1998, Frontiers in Bioscience, V3, pD997
[6]   Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles [J].
Cohen, H ;
Levy, RJ ;
Gao, J ;
Fishbein, I ;
Kousaev, V ;
Sosnowski, S ;
Slomkowski, S ;
Golomb, G .
GENE THERAPY, 2000, 7 (22) :1896-1905
[7]   Characterization of nanoparticle uptake by endothelial cells [J].
Davda, J ;
Labhasetwar, V .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 233 (1-2) :51-59
[8]   TRANSLOCATION OF RNA-COATED GOLD PARTICLES THROUGH THE NUCLEAR-PORES OF OOCYTES [J].
DWORETZKY, SI ;
FELDHERR, CM .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :575-584
[9]   SIGNAL-MEDIATED NUCLEAR TRANSPORT IN PROLIFERATING AND GROWTH-ARRESTED BALB/C 3T3 CELLS [J].
FELDHERR, CM ;
AKIN, D .
JOURNAL OF CELL BIOLOGY, 1991, 115 (04) :933-939
[10]   p53-oriented cancer therapies: Current progress [J].
Gallagher, WM ;
Brown, R .
ANNALS OF ONCOLOGY, 1999, 10 (02) :139-150